Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways

Cognitive impairment is highly prevalent in patients with Parkinson’s disease (PD) and causes adverse health outcomes. Novel procognitive therapies are needed to address this unmet need. It is now established that there is an increased risk of dementia in patients with type 2 diabetes mellitus (T2DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Holly, Tsitsi, Panagiota, Markaki, Ioanna, Aarsland, Dag, Svenningsson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373401/
https://www.ncbi.nlm.nih.gov/pubmed/30687888
http://dx.doi.org/10.1007/s40263-018-0601-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373401/
https://www.ncbi.nlm.nih.gov/pubmed/30687888
http://dx.doi.org/10.1007/s40263-018-0601-x

Ejemplares similares